Related Experiment Video
Updated: May 3, 2026
10:28
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
7.7K
Contemporary anticoagulation therapy in patients undergoing percutaneous intervention
Shaun Bhatty1, Asghar Ali, Ranjith Shetty
1Department of Internal Medicine, Cardiovascular Division, Virginia Commonwealth University Health System/Medical College of Virginia, Richmond, VA, USA.
Expert Review of Cardiovascular Therapy
|February 11, 2014
Summary
Optimal use of anticoagulants like heparin and bivalirudin is key for preventing blood clots and bleeding after cardiac catheterization. This review covers anticoagulant mechanisms and their appropriate application during percutaneous interventions.
Area of Science:
- Cardiology
- Pharmacology
- Hematology
Background:
- Anticoagulant therapy is essential for patients undergoing percutaneous interventions in cardiac catheterization.
- Various anticoagulant agents target different steps in the coagulation cascade to inhibit thrombin formation.
- Achieving optimal anticoagulation balances thrombosis prevention with bleeding risk for improved patient outcomes.
Purpose of the Study:
- To review the mechanisms of action for current and emerging anticoagulant therapies.
- To discuss the appropriate clinical use of these anticoagulants during percutaneous interventions.
- To highlight the importance of balancing anticoagulation for optimal patient outcomes.
Main Methods:
- Literature review of current and emerging anticoagulant therapies.
- Analysis of mechanisms of action targeting the coagulation cascade.
- Discussion of clinical application and outcome optimization during percutaneous interventions.
Main Results:
- Anticoagulant agents include unfractionated heparin, low-molecular-weight heparins, fondaparinux, and bivalirudin.
- These agents inhibit thrombin formation through various mechanisms.
- Optimal anticoagulation is critical for minimizing complications and improving patient outcomes.
Conclusions:
- Proper selection and use of anticoagulants are vital for percutaneous interventions.
- Understanding anticoagulant mechanisms aids in achieving the balance between efficacy and safety.
- Emerging therapies offer new strategies for optimizing anticoagulation in cardiac procedures.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
749
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749
01:27Peripheral Artery Disease III: Interprofessional Care
655
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655
01:28Acute Coronary Syndrome IV: Interprofessional Care
522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522